Management of infants with chronic lung disease of prematurity in the United Kingdom

Early Human Development

Volumn 81, Issue 2, 2005, Pages 165-170

  Shaw, N J ^a   Kotecha, Sailesh ^b  

^a LIVERPOOL WOMEN S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Bronchopulmonary dysplasia; Chronic lung disease of prematurity; Corticosteroids; Diuretics; Oxygen saturations; Oxygen therapy

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID; DEXAMETHASONE; DIURETIC AGENT; FUROSEMIDE; HYDROCHLOROTHIAZIDE; INFLUENZA VACCINE; OXYGEN; PALIVIZUMAB; PREDNISOLONE; SPIRONOLACTONE; STEROID; THIAZIDE DIURETIC AGENT;

ACUTE RESPIRATORY TRACT DISEASE; AIRWAY OBSTRUCTION; ARTIFICIAL VENTILATION; BLOOD OXYGEN TENSION; BRAIN HEMORRHAGE; CHRONIC LUNG DISEASE; CLINICAL TRIAL; DEVELOPMENTAL DISORDER; DRUG DOSE REDUCTION; ELECTROLYTE DISTURBANCE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; GROWTH RETARDATION; HEALTH CARE COST; HEALTH EDUCATION; HEARING LOSS; HEMODYNAMICS; HOME; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INFANT; INFLUENZA; INFLUENZA VACCINATION; KIDNEY CALCIFICATION; NEPHROTOXICITY; NERVE CELL DIFFERENTIATION; OTOTOXICITY; OXYGEN SATURATION; OXYGEN THERAPY; PHOSPHATE METABOLISM; PREMATURITY; REIMBURSEMENT; REVIEW; SEPSIS; SIDE EFFECT; TREATMENT CONTRAINDICATION; UNITED KINGDOM;

EID: 14644393051     PISSN: 03783782     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2004.12.008     Document Type: Article

References (20)

1. Anonymous Development of audit measures and guidelines in the management of neonatal respiratory distress syndrome. Report of a joint working group of the British Association of Perinatal Medicine and the Research Unit of the Royal College of Physicians Arch. Dis. Child. 67 1992 1221 1227
2. D.P. Cochran, and N.J. Shaw The use of pulse oximetry in the prevention of hyperoxia in preterm infants Eur. J. Pediatr. 154 1995 222 224
3. A. Ng, N.V. Subhedar, R.A. Primhak, and N.J. Shaw Arterial oxygen saturation profiles in healthy preterm infants Arch. Dis. Child. 79 1998 F64 F66
4. R. Gupta, C.W. Yoxall, N.V. Subhedar, and N.J. Shaw Individualised pulse oximetry limits in neonatal intensive care Arch. Dis. Child. 1999 F194 F196
5. The STOP-ROP Multicenter Study Group Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial: I. Primary outcomes Pediatrics 105 2 2000 (Feb.) 295 310
6. L.M. Askie, D.J. Henderson-Smart, L. Irwig, and J.M. Simpson Oxygen-saturation targets and outcomes in extremely preterm infants N. Engl. J. Med. 349 2003 959 967
7. A. Greenough, J. Alexander, S. Burgess, P.A.J. Chetcuti, S. Cox, and W. Lenney High versus restricted use of home oxygen therapy, health care utilisation and the cost of care in CLD infants Eur. J. Pediatr. 163 6 2004 292 296
8. H.L. Halliday, R.A. Ehrenkranz, and L.W. Doyle Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants (Cochrane Review) The Cochrane Library, Issue vol. 3 2004 John Wiley & Sons Chichester, UK
9. H.L. Halliday, R.A. Ehrenkranz, and L.W. Doyle Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants (Cochrane Review) The Cochrane Library, Issue vol. 3 2004 John Wiley & Sons Chichester, UK
10. H.L. Halliday, R.A. Ehrenkranz, and L.W. Doyle Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants (Cochrane Review) The Cochrane Library, Issue vol. 3 2004 John Wiley & Sons Chichester, UK
11. V. Shah, A. Ohlsson, H.L. Halliday, and M.S. Dunn Early administration of inhaled corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates (Cochrane Review) The Cochrane Library, Issue vol. 3 2004 John Wiley & Sons Chichester, UK
12. S.S. Shah, A. Ohlsson, H. Halliday, and V.S. Shah Inhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates (Cochrane Review) The Cochrane Library, Issue vol. 3 2004 John Wiley & Sons Chichester, UK
13. M.W. Beresford, R. Primhak, N.V. Subhedar, and N.J. Shaw Randomised double blind placebo controlled trial of inhaled fluticasone propionate in infants with chronic lung disease Arch. Dis. Child. Fetal Neonatal Ed. 87 1 2002 F62 F63
14. The British Thoracic Society Scottish Intercollegiate Guidelines Network Thorax 58 Suppl. I 2003 i1 i92
15. L.P. Brion, R.A. Primhak, and I. Ambrosio-Perez Diuretics acting on the distal renal tubule for preterm infants with (or developing) chronic lung disease (Cochrane Review) The Cochrane Library, Issue vol. 3 2004 John Wiley & Sons Chichester, UK
16. L.P. Brion, and R.A. Primhak Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease (Cochrane Review) The Cochrane Library, Issue vol. 3 2004 John Wiley & Sons Chichester, UK
17. L.C. Kao, D.J. Durand, and R.C. McCrea Randomised trial of long-term diuretic therapy for infants with oxygen dependent bronchopulmonary dysplasia J. Pediatr. 124 1994 772 781
18. S.G. Albersheim, A.J. Solimano, and A.K. Sharma Randomised double blind controlled trial of long term diuretic therapy for bronchopulmonary dysplasia J. Pediatr. 115 1989 615 620
19. D.J. Hoffman, J.S. Gerdes, and S. Abbasi Pulmonary function and electrolyte balance following spironolactone treatment in preterm infants with chronic lung disease: a double-blind, placebo-controlled randomised trial J. Perinatol. 20 2000 41 45
20. H. Dunbar, and S. Kotecha Domiciliary oxygen for infants with chronic lung disease of prematurity Care Crit. Ill 16 3 2000 90 93